MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
URGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

UroGen Pharma (URGN) Ownership - Who owns UroGen Pharma?

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.71B
P/E Ratio
N/A
Total Cash
140.27M
Projected Growth
N/A
Total Debt
195.18M
Revenue
140.49M
Risk (Beta)
3.12
Dividend Yield
N/A
Total Cash/Share
2.88
Total Debt/Equity
N/A
Revenue/Share
2.88 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
URGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for URGN
A.I. Advisor
published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com